> ## Content Index
> Fetch the complete content index at: https://sovereigntymonitor.eu/llms.txt
> Use this file to discover other available public pages before exploring further.

# Owkin licenses K Pro AI scientist and patient data to Servier for oncology research
- URL: https://sovereigntymonitor.eu/news/2026-09-11-owkin-servier-k-pro-license/
- Published: 2026-09-11T12:00:00.000Z
- Updated: 2026-09-18T13:55:06.000Z
- Description: Owkin, the Paris based AI biotech, licensed its K Pro AI Scientist platform and multimodal patient data from its MOSAIC network to French drugmaker Servier, extending an existing oncology research partnership. No financial terms were disclosed.
- Author: Reidar Balstad
- Tags: Industry, investment and R&D, #news, #verified, #ai-drafted

Verified AI-drafted [Owkin press release, 11 September 2026](https://www.owkin.com/newsfeed/owkin-to-license-k-pro-and-multimodal-data-to-servier-to-advance-oncology-research?ref=sovereigntymonitor.eu)

**What it does not test.** Does not disclose deal value, exclusivity terms, or any change in data ownership, infrastructure control or supply chain dependency between the two firms.

**How this item counts.** No movement: no answer to who owns, who operates, whose law governs or who made the parts changes. Weight 0\. licensing deal between two French firms; no change in own/operate/law/parts disclosed. [European Sovereignty Index](https://sovereigntymonitor.eu/sovereignty-index/)

**How this item was made.** Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. [How the record is made](https://sovereigntymonitor.eu/method/#how-the-record-is-made)